Donepezil for memory dysfunction in schizophrenia

Journal of Psychopharmacology

Volumn 16, Issue 3, 2002, Pages 267-270

  Howard, Andrew K ^a   Thornton, Allen E ^b   Altman, Siemion ^a   Honer, William G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Antipsychotic agents; Cholinergic system; Cholinesterase inhibitors; Cognition

Indexed keywords

BENZATROPINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; HALOPERIDOL; LORAZEPAM; PHENOTHIAZINE; QUETIAPINE; RISPERIDONE;

ADULT; AMNESIA; ARTICLE; CASE REPORT; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; FEMALE; HUMAN; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDANS; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PIPERIDINES; RETENTION (PSYCHOLOGY); SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0036726909     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600313     Document Type: Article

References (21)

1. Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies. Parkinson's disease, and Alzheimer's disease and in relation to neuroleptic medications
2. Illness duration and neuropsychological impairments in schizophrenia
3. Dementia as a complication of schizophrenia
4. Pharmacologic strategies for augmenting cognitive performance in schizophrenia
5. Effects of donepezil on cognition, symptoms, and movement disorders in patients with chronic schizophrenia
6. Effects of smoking abstinence on cognitive function in schizophrenia
7. What are the functional consequences of neurocognitive deficits in schizophrenia?
8. Donepezil therapy in clinical practice
9. A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments
10. Convergence of cognitive and adaptive decline in late-life schizophrenia
11. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence
12. Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia
13. Nicotinehaloperidol interactions and cognitive performance in schizophrenics
14. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
15. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders
16. Postmortem studies in schizophrenia
17. A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: Functional MRI correlates
18. A 24-week double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
19. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: Two sides of the same coin?
20. The effect of tandospirone, a serotoninlA agonist, on memory function in schizophrenia
21. Cholinergic hyperactivity and negative schizophrenic symptoms